Immune Targeting in Breast Cancer: In Whom and With What?
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Works matching IS 08909091 AND DT 2015 AND VI 29 AND IP 5
Results: 20
1
2
Subacute Headache in a Patient With Metastatic Gastric Cancer.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 5, p. 390
- By:
- Publication type:
- Article
3
Immune Targeting in Breast Cancer: In Whom and With What?
- Published in:
- Oncology (08909091), 2015, v. 29, n. 5, p. 386
- By:
- Publication type:
- Article
4
Subacute Headache in a Patient With Metastatic Gastric Cancer.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
5
Immune Targeting in Breast Cancer.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
6
Treatment of Meningioma, Including in Cases With No Further Surgical or Radiotherapy Options.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
7
Questions We Should Be Asking About Bevacizumab for Cervical Cancer.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
8
Is Classical Stereotactic Radiotherapy the Optimal Partner for Immunotherapy?
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
9
Is Radical Prostatectomy Appropriate for Very-High-Risk Prostate Cancer Patients? Yes.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
10
Is Radical Prostatectomy Appropriate for Very-High-Risk Prostate Cancer Patients? No.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
11
The Highs and Lows of Targeted Therapies.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
12
Treatment of Meningioma, Including in Cases With No Further Surgical or Radiotherapy Options.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 5, p. 369
- By:
- Publication type:
- Article
13
Immune Targeting in Breast Cancer.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 5, p. 375
- By:
- Publication type:
- Article
14
Is Classical Stereotactic Radiotherapy the Optimal Partner for Immunotherapy?
- Published in:
- Oncology (08909091), 2015, v. 29, n. 5, p. 340
- By:
- Publication type:
- Article
15
Questions We Should Be Asking About Bevacizumab for Cervical Cancer.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 5, p. 367
- By:
- Publication type:
- Article
16
Anti-Angiogenesis Therapy in Gynecologic Malignancies.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 5, p. 350
- By:
- Publication type:
- Article
17
Is Radical Prostatectomy Appropriate for Very-High-Risk Prostate Cancer Patients? No.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 5, p. 349
- By:
- Publication type:
- Article
18
Is Radical Prostatectomy Appropriate for Very-High-Risk Prostate Cancer Patients? Yes.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 5, p. 348
- By:
- Publication type:
- Article
19
Stereotactic Radiation Therapy Combined With Immunotherapy: Augmenting the Role of Radiation in Local and Systemic Treatment.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 5, p. 331
- By:
- Publication type:
- Article
20
The Highs and Lows of Targeted Therapies.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 5, p. 330
- By:
- Publication type:
- Article